Sequence of EZH2_HUMAN

[histone H3]-lysine27 N-trimethyltransferase

Q15910

746

85363

31945

Chen H.,Rossier C.,Antonarakis S.E.

Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2.

Genomics

38

30-37

1996

31946

Laible G.,Wolf A.,Dorn R.,Reuter G.,Nislow C.,Lebersorger A.,Popkin D.,Pillus L.,Jenuwein T.

Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres.

EMBO J.

16

3219-3232

1997

31947

Ota T.,Suzuki Y.,Nishikawa T.,Otsuki T.,Sugiyama T.,Irie R.,Wakamatsu A.,Hayashi K.,Sato H.,Nagai K.,Kimura K.,Makita H.,Sekine M.,Obayashi M.,Nishi T.,Shibahara T.,Tanaka T.,Ishii S.,Yamamoto J.,Saito K.,Kawai Y.,Isono Y.,Nakamura Y.,Nagahari K.,Murakami K.,Yasuda T.,Iwayanagi T.,Wagatsuma M.,Shiratori A.,Sudo H.,Hosoiri T.,Kaku Y.,Kodaira H.,Kondo H.,Sugawara M.,Takahashi M.,Kanda K.,Yokoi T.,Furuya T.,Kikkawa E.,Omura Y.,Abe K.,Kamihara K.,Katsuta N.,Sato K.,Tanikawa M.,Yamazaki M.,Ninomiya K.,Ishibashi T.,Yamashita H.,Murakawa K.,Fujimori K.,Tanai H.,Kimata M.,Watanabe M.,Hiraoka S.,Chiba Y.,Ishida S.,Ono Y.,Takiguchi S.,Watanabe S.,Yosida M.,Hotuta T.,Kusano J.,Kanehori K.,Takahashi-Fujii A.,Hara H.,Tanase T.-O.,Nomura Y.,Togiya S.,Komai F.,Hara R.,Takeuchi K.,Arita M.,Imose N.,Musashino K.,Yuuki H.,Oshima A.,Sasaki N.,Aotsuka S.,Yoshikawa Y.,Matsunawa H.,Ichihara T.,Shiohata N.,Sano S.,Moriya S.,Momiyama H.,Satoh N.,Takami S.,Terashima Y.,Suzuki O.,Nakagawa S.,Senoh A.,Mizoguchi H.,Goto Y.,Shimizu F.,Wakebe H.,Hishigaki H.,Watanabe T.,Sugiyama A.,Takemoto M.,Kawakami B.,Yamazaki M.,Watanabe K.,Kumagai A.,Itakura S.,Fukuzumi Y.,Fujimori Y.,Komiyama M.,Tashiro H.,Tanigami A.,Fujiwara T.,Ono T.,Yamada K.,Fujii Y.,Ozaki K.,Hirao M.,Ohmori Y.,Kawabata A.,Hikiji T.,Kobatake N.,Inagaki H.,Ikema Y.,Okamoto S.,Okitani R.,Kawakami T.,Noguchi S.,Itoh T.,Shigeta K.,Senba T.,Matsumura K.,Nakajima Y.,Mizuno T.,Morinaga M.,Sasaki M.,Togashi T.,Oyama M.,Hata H.,Watanabe M.,Komatsu T.,Mizushima-Sugano J.,Satoh T.,Shirai Y.,Takahashi Y.,Nakagawa K.,Okumura K.,Nagase T.,Nomura N.,Kikuchi H.,Masuho Y.,Yamashita R.,Nakai K.,Yada T.,Nakamura Y.,Ohara O.,Isogai T.,Sugano S.

Complete sequencing and characterization of 21,243 full-length human cDNAs.

Nat. Genet.

36

40-45

2004

31948

Hillier L.W.,Fulton R.S.,Fulton L.A.,Graves T.A.,Pepin K.H.,Wagner-McPherson C.,Layman D.,Maas J.,Jaeger S.,Walker R.,Wylie K.,Sekhon M.,Becker M.C.,O'Laughlin M.D.,Schaller M.E.,Fewell G.A.,Delehaunty K.D.,Miner T.L.,Nash W.E.,Cordes M.,Du H.,Sun H.,Edwards J.,Bradshaw-Cordum H.,Ali J.,Andrews S.,Isak A.,Vanbrunt A.,Nguyen C.,Du F.,Lamar B.,Courtney L.,Kalicki J.,Ozersky P.,Bielicki L.,Scott K.,Holmes A.,Harkins R.,Harris A.,Strong C.M.,Hou S.,Tomlinson C.,Dauphin-Kohlberg S.,Kozlowicz-Reilly A.,Leonard S.,Rohlfing T.,Rock S.M.,Tin-Wollam A.-M.,Abbott A.,Minx P.,Maupin R.,Strowmatt C.,Latreille P.,Miller N.,Johnson D.,Murray J.,Woessner J.P.,Wendl M.C.,Yang S.-P.,Schultz B.R.,Wallis J.W.,Spieth J.,Bieri T.A.,Nelson J.O.,Berkowicz N.,Wohldmann P.E.,Cook L.L.,Hickenbotham M.T.,Eldred J.,Williams D.,Bedell J.A.,Mardis E.R.,Clifton S.W.,Chissoe S.L.,Marra M.A.,Raymond C.,Haugen E.,Gillett W.,Zhou Y.,James R.,Phelps K.,Iadanoto S.,Bubb K.,Simms E.,Levy R.,Clendenning J.,Kaul R.,Kent W.J.,Furey T.S.,Baertsch R.A.,Brent M.R.,Keibler E.,Flicek P.,Bork P.,Suyama M.,Bailey J.A.,Portnoy M.E.,Torrents D.,Chinwalla A.T.,Gish W.R.,Eddy S.R.,McPherson J.D.,Olson M.V.,Eichler E.E.,Green E.D.,Waterston R.H.,Wilson R.K.

The DNA sequence of human chromosome 7.

Nature

424

157-164

2003

31950

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

Genome Res.

14

2121-2127

2004

31951

Hobert O.,Jallal B.,Ullrich A.

Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression.

Mol. Cell. Biol.

16

3066-3073

1996

31952

Cardoso C.,Timsit S.,Villard L.,Khrestchatisky M.,Fontes M.,Colleaux L.

Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein.

Hum. Mol. Genet.

7

679-684

1998

31953

Sewalt R.G.A.B.,van der Vlag J.,Gunster M.J.,Hamer K.M.,den Blaauwen J.L.,Satijn D.P.E.,Hendrix T.,van Driel R.,Otte A.P.

Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.

Mol. Cell. Biol.

18

3586-3595

1998

31954

van der Vlag J.,Otte A.P.

Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation.

Nat. Genet.

23

474-478

1999

31955

Satijn D.P.E.,Hamer K.M.,den Blaauwen J.,Otte A.P.

The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos.

Mol. Cell. Biol.

21

1360-1369

2001

31956

Kuzmichev A.,Nishioka K.,Erdjument-Bromage H.,Tempst P.,Reinberg D.

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

Genes Dev.

16

2893-2905

2002

31957

Sewalt R.G.A.B.,Lachner M.,Vargas M.,Hamer K.M.,den Blaauwen J.L.,Hendrix T.,Melcher M.,Schweizer D.,Jenuwein T.,Otte A.P.

Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.

Mol. Cell. Biol.

22

5539-5553

2002

31958

Cao R.,Wang L.,Wang H.,Xia L.,Erdjument-Bromage H.,Tempst P.,Jones R.S.,Zhang Y.

Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Science

298

1039-1043

2002

31959

Bracken A.P.,Pasini D.,Capra M.,Prosperini E.,Colli E.,Helin K.

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

EMBO J.

22

5323-5335

2003

31960

Pasini D.,Bracken A.P.,Jensen M.R.,Lazzerini Denchi E.,Helin K.

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.

EMBO J.

23

4061-4071

2004

31961

Kirmizis A.,Bartley S.M.,Kuzmichev A.,Margueron R.,Reinberg D.,Green R.,Farnham P.J.

Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

Genes Dev.

18

1592-1605

2004

31962

Kuzmichev A.,Jenuwein T.,Tempst P.,Reinberg D.

Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.

Mol. Cell

14

183-193

2004

31963

Cao R.,Zhang Y.

SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.

Mol. Cell

15

57-67

2004

31964

Tang X.,Milyavsky M.,Shats I.,Erez N.,Goldfinger N.,Rotter V.

Activated p53 suppresses the histone methyltransferase EZH2 gene.

Oncogene

23

5759-5769

2004

31965

Epping M.T.,Wang L.,Edel M.J.,Carlee L.,Hernandez M.,Bernards R.

The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.

Cell

122

835-847

2005

31966

Kuzmichev A.,Margueron R.,Vaquero A.,Preissner T.S.,Scher M.,Kirmizis A.,Ouyang X.,Brockdorff N.,Abate-Shen C.,Farnham P.J.,Reinberg D.

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.

Proc. Natl. Acad. Sci. U.S.A.

102

1859-1864

2005

31967

Cha T.-L.,Zhou B.P.,Xia W.,Wu Y.,Yang C.-C.,Chen C.-T.,Ping B.,Otte A.P.,Hung M.-C.

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.

Science

310

306-310

2005

31968

Olsen J.V.,Blagoev B.,Gnad F.,Macek B.,Kumar C.,Mortensen P.,Mann M.

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Cell

127

635-648

2006

31969

Bracken A.P.,Dietrich N.,Pasini D.,Hansen K.H.,Helin K.

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

Genes Dev.

20

1123-1136

2006

31970

Martin C.,Cao R.,Zhang Y.

Substrate preferences of the EZH2 histone methyltransferase complex.

J. Biol. Chem.

281

8365-8370

2006

31971

Etchegaray J.P.,Yang X.,DeBruyne J.P.,Peters A.H.,Weaver D.R.,Jenuwein T.,Reppert S.M.

The polycomb group protein EZH2 is required for mammalian circadian clock function.

J. Biol. Chem.

281

21209-21215

2006

31972

Beausoleil S.A.,Villen J.,Gerber S.A.,Rush J.,Gygi S.P.

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

Nat. Biotechnol.

24

1285-1292

2006

31973

Vire E.,Brenner C.,Deplus R.,Blanchon L.,Fraga M.,Didelot C.,Morey L.,Van Eynde A.,Bernard D.,Vanderwinden J.-M.,Bollen M.,Esteller M.,Di Croce L.,de Launoit Y.,Fuks F.

The Polycomb group protein EZH2 directly controls DNA methylation.

Nature

439

871-874

2006

31975

Kim D.H.,Villeneuve L.M.,Morris K.V.,Rossi J.J.

Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells.

Nat. Struct. Mol. Biol.

13

793-797

2006

31976

Kotake Y.,Cao R.,Viatour P.,Sage J.,Zhang Y.,Xiong Y.

pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.

Genes Dev.

21

49-54

2007

31977

Bracken A.P.,Kleine-Kohlbrecher D.,Dietrich N.,Pasini D.,Gargiulo G.,Beekman C.,Theilgaard-Moench K.,Minucci S.,Porse B.T.,Marine J.-C.,Hansen K.H.,Helin K.

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.

Genes Dev.

21

525-530

2007

31978

Schlesinger Y.,Straussman R.,Keshet I.,Farkash S.,Hecht M.,Zimmerman J.,Eden E.,Yakhini Z.,Ben-Shushan E.,Reubinoff B.E.,Bergman Y.,Simon I.,Cedar H.

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.

Nat. Genet.

39

232-236

2007

31979

Cantin G.T.,Yi W.,Lu B.,Park S.K.,Xu T.,Lee J.-D.,Yates J.R. III

Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.

J. Proteome Res.

7

1346-1351

2008

31980

Daub H.,Olsen J.V.,Bairlein M.,Gnad F.,Oppermann F.S.,Korner R.,Greff Z.,Keri G.,Stemmann O.,Mann M.

Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

Mol. Cell

31

438-448

2008

31981

Margueron R.,Li G.,Sarma K.,Blais A.,Zavadil J.,Woodcock C.L.,Dynlacht B.D.,Reinberg D.

Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.

Mol. Cell

32

503-518

2008

31982

Cao R.,Wang H.,He J.,Erdjument-Bromage H.,Tempst P.,Zhang Y.

Role of hPHF1 in H3K27 methylation and Hox gene silencing.

Mol. Cell. Biol.

28

1862-1872

2008

31983

Sarma K.,Margueron R.,Ivanov A.,Pirrotta V.,Reinberg D.

Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.

Mol. Cell. Biol.

28

2718-2731

2008

31984

Riising E.M.,Boggio R.,Chiocca S.,Helin K.,Pasini D.

The polycomb repressive complex 2 is a potential target of SUMO modifications.

PLoS ONE

3

0-0

2008

31985

Dephoure N.,Zhou C.,Villen J.,Beausoleil S.A.,Bakalarski C.E.,Elledge S.J.,Gygi S.P.

A quantitative atlas of mitotic phosphorylation.

Proc. Natl. Acad. Sci. U.S.A.

105

10762-10767

2008

31986

Gauci S.,Helbig A.O.,Slijper M.,Krijgsveld J.,Heck A.J.,Mohammed S.

Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

Anal. Chem.

81

4493-4501

2009

31987

Mayya V.,Lundgren D.H.,Hwang S.-I.,Rezaul K.,Wu L.,Eng J.K.,Rodionov V.,Han D.K.

Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

Sci. Signal.

2

0-0

2009

31988

Chen S.,Bohrer L.R.,Rai A.N.,Pan Y.,Gan L.,Zhou X.,Bagchi A.,Simon J.A.,Huang H.

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.

Nat. Cell Biol.

12

1108-1114

2010

31989

Olsen J.V.,Vermeulen M.,Santamaria A.,Kumar C.,Miller M.L.,Jensen L.J.,Gnad F.,Cox J.,Jensen T.S.,Nigg E.A.,Brunak S.,Mann M.

Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

Sci. Signal.

3

0-0

2010

31990

Zhang Y.,Yang X.,Gui B.,Xie G.,Zhang D.,Shang Y.,Liang J.

Corepressor protein CDYL functions as a molecular bridge between polycomb repressor complex 2 and repressive chromatin mark trimethylated histone lysine 27.

J. Biol. Chem.

286

42414-42425

2011

31991

Rigbolt K.T.,Prokhorova T.A.,Akimov V.,Henningsen J.,Johansen P.T.,Kratchmarova I.,Kassem M.,Mann M.,Olsen J.V.,Blagoev B.

System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

Sci. Signal.

4

0-0

2011

31992

Lee J.M.,Lee J.S.,Kim H.,Kim K.,Park H.,Kim J.Y.,Lee S.H.,Kim I.S.,Kim J.,Lee M.,Chung C.H.,Seo S.B.,Yoon J.B.,Ko E.,Noh D.Y.,Kim K.I.,Kim K.K.,Baek S.H.

EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.

Mol. Cell

48

572-586

2012

31993

Zhou H.,Di Palma S.,Preisinger C.,Peng M.,Polat A.N.,Heck A.J.,Mohammed S.

Toward a comprehensive characterization of a human cancer cell phosphoproteome.

J. Proteome Res.

12

260-271

2013

31994

Chu C.S.,Lo P.W.,Yeh Y.H.,Hsu P.H.,Peng S.H.,Teng Y.C.,Kang M.L.,Wong C.H.,Juan L.J.

O-GlcNAcylation regulates EZH2 protein stability and function.

Proc. Natl. Acad. Sci. U.S.A.

111

1355-1360

2014

31995

Hendriks I.A.,Lyon D.,Young C.,Jensen L.J.,Vertegaal A.C.,Nielsen M.L.

Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

Nat. Struct. Mol. Biol.

24

325-336

2017

31996

Li D.,Song H.,Mei H.,Fang E.,Wang X.,Yang F.,Li H.,Chen Y.,Huang K.,Zheng L.,Tong Q.

Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4.

Nat. Commun.

9

2829-2829

2018

31997

Jain S.U.,Do T.J.,Lund P.J.,Rashoff A.Q.,Diehl K.L.,Cieslik M.,Bajic A.,Juretic N.,Deshmukh S.,Venneti S.,Muir T.W.,Garcia B.A.,Jabado N.,Lewis P.W.

PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism.

Nat. Commun.

10

2146-2146

2019

31998

Ragazzini R.,Perez-Palacios R.,Baymaz I.H.,Diop S.,Ancelin K.,Zielinski D.,Michaud A.,Givelet M.,Borsos M.,Aflaki S.,Legoix P.,Jansen P.W.T.C.,Servant N.,Torres-Padilla M.E.,Bourc'his D.,Fouchet P.,Vermeulen M.,Margueron R.

EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells.

Nat. Commun.

10

3858-3858

2019

31999

Huebner J.M.,Mueller T.,Papageorgiou D.N.,Mauermann M.,Krijgsveld J.,Russell R.B.,Ellison D.W.,Pfister S.M.,Pajtler K.W.,Kool M.

EZHIP / CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.

Neuro-oncol.

21

878-889

2019

32000

Yu Z.,Feng J.,Wang W.,Deng Z.,Zhang Y.,Xiao L.,Wang Z.,Liu C.,Liu Q.,Chen S.,Wu M.

The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically.

Oncogene

39

3163-3178

2020

32001

Morin R.D.,Johnson N.A.,Severson T.M.,Mungall A.J.,An J.,Goya R.,Paul J.E.,Boyle M.,Woolcock B.W.,Kuchenbauer F.,Yap D.,Humphries R.K.,Griffith O.L.,Shah S.,Zhu H.,Kimbara M.,Shashkin P.,Charlot J.F.,Tcherpakov M.,Corbett R.,Tam A.,Varhol R.,Smailus D.,Moksa M.,Zhao Y.,Delaney A.,Qian H.,Birol I.,Schein J.,Moore R.,Holt R.,Horsman D.E.,Connors J.M.,Jones S.,Aparicio S.,Hirst M.,Gascoyne R.D.,Marra M.A.

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Nat. Genet.

42

181-185

2010

32002

Ernst T.,Chase A.J.,Score J.,Hidalgo-Curtis C.E.,Bryant C.,Jones A.V.,Waghorn K.,Zoi K.,Ross F.M.,Reiter A.,Hochhaus A.,Drexler H.G.,Duncombe A.,Cervantes F.,Oscier D.,Boultwood J.,Grand F.H.,Cross N.C.

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.

Nat. Genet.

42

722-726

2010

32003

Yap D.B.,Chu J.,Berg T.,Schapira M.,Cheng S.W.,Moradian A.,Morin R.D.,Mungall A.J.,Meissner B.,Boyle M.,Marquez V.E.,Marra M.A.,Gascoyne R.D.,Humphries R.K.,Arrowsmith C.H.,Morin G.B.,Aparicio S.A.

Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.

Blood

117

2451-2459

2011

32004

Jankowska A.M.,Makishima H.,Tiu R.V.,Szpurka H.,Huang Y.,Traina F.,Visconte V.,Sugimoto Y.,Prince C.,O'Keefe C.,Hsi E.D.,List A.,Sekeres M.A.,Rao A.,McDevitt M.A.,Maciejewski J.P.

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

Blood

118

3932-3941

2011

32005

Tatton-Brown K.,Hanks S.,Ruark E.,Zachariou A.,Duarte S.V.,Ramsay E.,Snape K.,Murray A.,Perdeaux E.R.,Seal S.,Loveday C.,Banka S.,Clericuzio C.,Flinter F.,Magee A.,McConnell V.,Patton M.,Raith W.,Rankin J.,Splitt M.,Strenger V.,Taylor C.,Wheeler P.,Temple K.I.,Cole T.,Douglas J.,Rahman N.

Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height.

Oncotarget

2

1127-1133

2011

32006

Gibson W.T.,Hood R.L.,Zhan S.H.,Bulman D.E.,Fejes A.P.,Moore R.,Mungall A.J.,Eydoux P.,Babul-Hirji R.,An J.,Marra M.A.,Chitayat D.,Boycott K.M.,Weaver D.D.,Jones S.J.

Mutations in EZH2 cause Weaver syndrome.

Am. J. Hum. Genet.

90

110-118

2012

32007

McCabe M.T.,Graves A.P.,Ganji G.,Diaz E.,Halsey W.S.,Jiang Y.,Smitheman K.N.,Ott H.M.,Pappalardi M.B.,Allen K.E.,Chen S.B.,Della Pietra A. III,Dul E.,Hughes A.M.,Gilbert S.A.,Thrall S.H.,Tummino P.J.,Kruger R.G.,Brandt M.,Schwartz B.,Creasy C.L.

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).

Proc. Natl. Acad. Sci. U.S.A.

109

2989-2994

2012

32008

Al-Salem A.,Alshammari M.J.,Hassan H.,Alazami A.M.,Alkuraya F.S.

Weaver syndrome and defective cortical development: a rare association.

Am. J. Med. Genet. A

161A

225-227

2013

32009

Cohen A.S.,Yap D.B.,Lewis M.E.,Chijiwa C.,Ramos-Arroyo M.A.,Tkachenko N.,Milano V.,Fradin M.,McKinnon M.L.,Townsend K.N.,Xu J.,Van Allen M.I.,Ross C.J.,Dobyns W.B.,Weaver D.D.,Gibson W.T.

Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.

Hum. Mutat.

37

301-307

2016

32010

Imagawa E.,Higashimoto K.,Sakai Y.,Numakura C.,Okamoto N.,Matsunaga S.,Ryo A.,Sato Y.,Sanefuji M.,Ihara K.,Takada Y.,Nishimura G.,Saitsu H.,Mizuguchi T.,Miyatake S.,Nakashima M.,Miyake N.,Soejima H.,Matsumoto N.

Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome.

Hum. Mutat.

38

637-648

2017